Troglitazone induces apoptosis in gastric cancer cells through the NAG-1 pathway

Molecular Medicine Reports

Volumn 4, Issue 1, 2011, Pages 93-97

  Wang, Chunhui ^a   Wang, Jing ^a   Bai, Ping ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Egr 1; Gastric cancer; Non steroidal anti inflammatory drug activated gene; Troglitazone

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; NONSTEROIDAL ANTIINFLAMMATORY DRUG ACTIVATED GENE 1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TROGLITAZONE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; NICK END LABELING; STOMACH CANCER; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE; CHROMANS; EARLY GROWTH RESPONSE PROTEIN 1; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; STOMACH NEOPLASMS; THIAZOLIDINEDIONES;

EID: 78651388245     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2010.381     Document Type: Article

References (21)

1. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM and Kliewer SA: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPARγ). J Biol Chem 270: 12953-12956, 1995.
2. Wijk JP and Rabelink TJ: Impact of thiazolidinedione therapy on atherogenesis. Curr Atheroscler Rep 7: 369-374, 2005.
3. Sung B, Park S, Yu BP and Chung HY: Amelioration of age-related inflammation and oxidative stress by PPARgamma activator: suppression of NF-kappaB by 2,4-thiazolidinedione. Exp Gerontol 41: 590-599, 2006. (Pubitemid 43867228)
4. Weng JR, Chen CY, Pinzone JJ, Ringel MD and Chen CS: Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones. Endocr Relat Cancer 13: 401-413, 2006.
5. Yamaguchi K, Lee SH, Eling TE and Baek SJ: A novel peroxisome proliferator-activated receptor gamma ligand, MCC-555, induces apoptosis via posttranscriptional regulation of NAG-1 in colorectal cancer cells. Mol Cancer Ther 5: 1352-1361, 2006. (Pubitemid 43881329)
6. Demetri GD, Fletcher CD, Mueller E, Sarraf P, Naujoks R, Campbell N, Spiegelman BM and Singer S: Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma. Proc Natl Acad Sci USA 96: 3951-3956, 1999. (Pubitemid 29169017)
7. Takahashi N, Okumura T, Motomura W, Fujimoto Y, Kawabata I and Kohgo Y: Activation of PPARgamma inhibits cell growth and induces apoptosis in human gastric cancer cells. FEBS Lett 455: 135-139, 1999. (Pubitemid 29322796)
8. Huang H, Campbell SC, Bedford DF, Nelius T, Veliceasa D, Shroff EH, Henkin J, Schneider A, Bouck N and Volpert OV: Peroxisome proliferator-activated receptor gamma ligands improve the antitumor efficacy of thrombospondin peptide ABT510. Mol Cancer Res 2: 541-550, 2004. (Pubitemid 39403382)
9. Coras R, Hölsken A, Seufert S, Hauke J, Eyüpoglu IY, Reichel M Tränkle C, Siebzehnrübl FA, Buslei R, Blümcke I and Hahnen E: The peroxisome proliferator-activated receptor-gamma agonist troglitazone inhibits transforming growth factor-beta-mediated glioma cell migration and brain invasion. Mol Cancer Ther 6: 1745-1754, 2007. (Pubitemid 46954051)
10. Rumi MA, Ishihara S, Kadowaki Y, Ortega-Cava CF, Kazumori H, Kawashima K, Yoshino N, Yuki T, Ishimura N and Kinoshita Y: Peroxisome proliferator- activated receptor gamma-dependent and -independent growth inhibition of gastrointestinal tumour cells. Genes Cells 9: 1113-1123, 2004. (Pubitemid 39467983)
11. Eling TE, Baek SJ, Shim M and Lee CH: NSAID activated gene (NAG-1), a modulator of tumorigenesis. J Biochem Mol Biol 39: 649-655, 2006. (Pubitemid 44892888)
12. Kim JS, Baek SJ, Sali T and Eling TE: The conventional nonsteroidal anti-inflammatory drug sulindac sulfide arrests ovarian cancer cell growth via the expression of NAG-1/MIC-1/GDF-15. Mol Cancer Ther 4: 487-493 2005. (Pubitemid 40443934)
13. Baek SJ, Okazaki R, Lee SH, Martinez J, Kim JS, Yamaguchi K, Mishina Y, Martin DW, Shoieb A, McEntee MF, Eling TE: Nonsteroidal anti-inflammatory drug-activated gene-1 over expression in transgenic mice suppresses intestinal neoplasia. Gastroenterology 131: 1553-1560, 2006. (Pubitemid 44708948)
14. Lee SH, Krisanapun C and Baek SJ: NSAID-activated gene-1 as a molecular target for capsaicin-induced apoptosis through a novel molecular mechanism involving GSK3beta, C/EBPbeta and ATF3. Carcinogenesis 31: 719-728, 2010.
15. Baek SJ, Kim KS, Nixon JB, Wilson LC and Eling TE: Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptoic and antitumorigenic activities. Mol Pharmacol 59: 901-908, 2001.
16. Jang TJ, Kang HJ, Kim JR and Yang CH: Non-steroidal anti-inflammatory drug activated gene (NAG-1) expression is closely related to death receptor-4 and -5 induction, which may explain sulindac sulfide-induced gastric cancer cell apoptosis. Carcinogenesis 25: 1853-1858, 2004.
17. Wang C, Ouyang Q, Tang C, Liu R and Huang M: Induction of NAG-1 gene expression in colon cancer cells by non-steroidal anti-inflammatory drugs. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 24: 880-883, 2007.
18. Kobuke T, Tazuma S, Hyogo H and Chayama K: A ligand for peroxisome proliferator-activated receptor gamma inhibits human cholangiocarcinoma cell growth: potential molecular targeting strategy for cholangioma. Dig Dis Sci 51: 1650-1657, 2006. (Pubitemid 44379312)
19. Baek SJ, Kim JS, Nixon JB, DiAugustine RP and Eling TE: Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1. J Biol Chem 279: 6883-6892, 2004.
20. Shimoyamada H, Yazawa T, Sato H, Okudela K, Ishii J, Sakaeda M, Kashiwagi K, Suzuki T, Mitsui H, Woo T, Tajiri M, Ohmori T, Ogura T, Masuda M, Oshiro H and Kitamura H.:Early growth response-1 induces and enhances vascular endothelial growth factor-a expression in lung cancer cells. Am J Pathol 177: 70-83, 2010.
21. Parra E and Ferreira J: The effect of siRNA-Egr-1 and camptothecin on growth and chemosensitivity of breast cancer cell lines. Oncol Rep 23: 1159-1165, 2010.